10. Juli 2025|
AI
|5 months agoSwiss Insurers Raise Alarm Over Weight Loss Drug Costs
Health insurers express concern as 40,000 Swiss residents receive Wegovy under basic insurance, warning of potential cost explosion in healthcare system.
AI
Generated IllustrationKey Takeaways
AI
- Since March 2024, Swiss basic health insurance has reimbursed Wegovy under strict conditions.
- Approximately 40,000 people received Wegovy under mandatory insurance in 2024.
- Insurers spent CHF 43 million on the drug in 2024.
- In the first three months of 2025 alone, insurers spent half of the total amount spent in all of 2024.
- Reimbursement for Wegovy is currently authorized until the end of February 2027.
By The Numbers
40,000
Patients
CHF 43 million
Cost
CHF 300 million
Projected Annual Cost
250,000
Monthly Doses
They Said
"If 2% of the adult population received Wegovy, the annual cost could reach CHF 300 million."
1
Explosive Uptake Strains Insurance Models
2
Financial Forecasts Turn Ominous
3
Weighing Chronic Illness Against Costs
4